Freedom Broker maintains Merck & Co at Hold, raises price target to $140 from $125
Thời gian đọc: dưới 1 phút
Freedom Broker maintained Merck & Co at Hold and raised its price target to $140 from $125, a 12.0% increase.
The price target implies a downside of 5.6% from the Nov 2 close of $148.36.
Recent analyst actions on Merck & Co
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| Nov 2 | Cantor Fitzgerald | Maintains | Neutral | $155 |
| Oct 30 | JP Morgan | Maintains | Overweight | $175 |
| Oct 30 | RBC Capital | Maintains | Sector Perform | $140 |
| Oct 30 | Guggenheim | Maintains | Buy | $171 |
| Oct 26 | Barclays | Maintains | Overweight | $180 |
Across the five most recent analyst notes published on Merck & Co over the past 30 days, price targets range from $140 to $180.
Explore more price target data and ratings for Merck & Co on the Forecasts tab, and track all previous and future analyst recommendations in the dedicated News Flow.
Select reference data provided by Benzinga. This information is not a recommendation for what you should do personally and does not constitute investment advice.
Đọc toàn bộ bài viết
Thoải mái đọc các bài cập nhật từ chuyên gia phân tích và mọi bài viết khác trên TradingView, không giới hạn.